Our previous results were generated by genetic manipulations of ERK5 in immune-deficient mice and in the present study we moved our research to the next step by using a specific small molecule inhibitor of ERK5 on mesothelioma tumor growth in immune competent mice. Here, MAPK7 is linked to mesothelioma.